Mochi Health Review 2026: The GLP-1 Platform Built Around Obesity Medicine
Mochi Health is one of the biggest GLP-1 telehealth services in the US. It pairs board-certified providers, including obesity medicine doctors, with compounded semaglutide and tirzepatide priced by dose.
One of the biggest GLP-1 telehealth services in the US, with board-certified providers that include obesity medicine doctors. Semaglutide comes as a weekly shot or a pill. Since August 2026, the medicine price rises with your dose. The pharmacy record is the fair knock: the Aequita shutdown in 2025 was serious.
On this page
What you will actually pay
We may earn a commission if you sign up through a link. It never affects the ranking. How we review
First-time GLP-1 users who want the most affordable entry point (price scales with dose: $60–$99/mo medication from 0.22 to 2.67 mg, $151 at 4.5 mg and $189 at 6.48 mg, + $79/mo membership)
Get startedPatients who want the dual GIP/GLP-1 mechanism for greater weight loss (price scales with dose, $90–$199/mo medication + $79/mo membership)
Get startedNeedle-averse patients who prefer a weekly pill ($62–$89/mo medication by dose, 1.25 to 7 mg, + $79/mo membership)
Get startedPatients who require or prefer FDA-approved branded medications, or want a shot at insurance coverage
Get startedWomen who want FDA-approved hormone therapy for menopause symptoms on the same membership
Get startedLowers the membership to about $69, $59 or $49 a month if you commit up front
Get startedPeople with private health insurance: visits are billed to the plan, and the membership drops to under $20 a month. Medicine billed separately; Medicare and Medicaid not supported yet
Get startedEstimated all-in cost: $1,668–$3,336/yr (compounded semaglutide to tirzepatide, membership included; $79 less in year one where the free first month applies; branded medication without a successful PA runs higher)
- ✓ More than 400 board-certified providers, including doctors board-certified in obesity medicine
- ✓ Semaglutide as a weekly shot or a weekly pill, plus tirzepatide and a microdosing plan
- ✓ Compounded medicine is priced by dose and stays well below brand-name cash prices: about $60–$190/mo for semaglutide, about $90–$200/mo for tirzepatide
- ✓ One of the biggest GLP-1 telehealth services, with more than 500,000 members by Mochi's count
- ✓ You compare partner pharmacies on price and speed and choose where your prescription goes
- ✓ Founded by physician Myra Ahmad; clinical focus on metabolic and hormonal health
- ✓ Branded Ozempic, Wegovy, Mounjaro, Zepbound available, with prior-authorization support for patients whose insurance might cover them
- ✓ Menopausal and perimenopausal patients supported by metabolically informed providers
- ✓ Also offers menopause hormone therapy on the same membership: FDA-approved estradiol pill or patch, and progesterone
- ✓ Prepaid membership brings the fee down to about $49 a month on a 12-month plan
- ✓ FSA/HSA accepted for membership, and a superbill is available on request for reimbursement attempts
- ⚑ Pharmacy track record is spotty: the Aequita shutdown in March 2025 caused shipping delays
- ⚑ New reporting in 2026 added detail on the Aequita failures, so ask which pharmacy fills your prescription
- ⚑ Labs not included; patients must arrange monitoring independently
- ⚑ Cash-pay for membership and all compounded medication; branded GLP-1s route through insurance only if a prior authorization Mochi submits is approved. With private insurance, the Covered With Mochi plan bills visits to your plan instead
- ⚑ The FDA's April 2026 proposal to keep GLP-1s off the 503B bulks list adds some supply risk, mainly for outsourcing facilities
- ⚑ The $79/mo membership comes on top of the medicine. It is already in the compounded all-in prices above, but adds to any brand-name cash price. The first month is free for new members, though not in every state
What Is Mochi Health?
Mochi Health is a telehealth company based in San Francisco. Physician Myra Ahmad founded it in 2022. Mochi says more than 500,000 members have joined, and you can sign up from anywhere in the United States.
Its care team counts more than 400 board-certified providers. Several of its doctors are also board-certified in obesity medicine, a specialty built on the biology of weight. That sets Mochi apart from services that treat GLP-1s as a side offering.
Mochi covers weight loss, menopause, skin care, hair loss and more. GLP-1 medicines are still its main product. These are weekly or daily drugs that curb appetite and steady blood sugar.
Mochi now also works like a pharmacy marketplace. You compare its partner pharmacies on price and speed, then choose one. Your medicine ships to your door.
How Mochi Health Works
Sign-up starts with an online health questionnaire. You share your history, your goals and any recent lab results. Then you meet a licensed provider on a video visit. If a GLP-1 fits, the provider writes the prescription.
- Intake: an online form about your weight, health history and goals
- Video visit: a live visit with a licensed provider, and you can switch providers anytime
- Pharmacy: you compare Mochi's partner pharmacies and pick where your prescription goes
- Delivery: the medicine ships straight to your door
- Follow-up: check-ins through the patient portal, with dose changes as needed
Lab tests are not part of the membership. If your provider asks for bloodwork, you arrange it and pay for it separately, often through your own doctor.
Mochi does not bill insurance for its membership or for compounded medicine. For a brand-name GLP-1, its team can file a prior authorization, which is your insurer's advance approval. Read how Mochi handles insurance, FSA and HSA for the details.
Medications: Semaglutide Shots and Pills, Tirzepatide and Brand Names
Mochi's medication menu is one of the broadest in telehealth. Its main offer is compounded semaglutide, the drug in Ozempic and Wegovy. Compounded means a pharmacy mixes the medicine itself, so it is not FDA-approved.
You can take compounded semaglutide as a weekly shot or a weekly pill. Mochi also offers compounded tirzepatide, the drug in Zepbound and Mounjaro. A microdosing plan uses lower doses for people who react strongly. Microdosing is not an FDA-approved way to dose.
Brand-name, FDA-approved drugs are on the menu too. They suit anyone who wants the approved version or hopes insurance will help pay.
- Compounded semaglutide shot: weekly injection, with doses from 0.22 mg to 6.48 mg
- Compounded semaglutide pill: a weekly pill for people who would rather skip needles
- Compounded tirzepatide shot: a weekly injection that acts on two gut hormones, GIP and GLP-1
- Microdosing plan: lower doses of semaglutide or tirzepatide, set by your provider
- Compounded orforglipron pill: a daily pill made from the same drug as Lilly's Foundayo
- Brand names: Wegovy as a pen or pill, Ozempic, Zepbound, Mounjaro and Foundayo, priced separately
For women in perimenopause or menopause, the pill option matters. Midlife hormone shifts often move fat toward the belly and make blood sugar harder to manage. GLP-1 drugs work on appetite and blood sugar. A pill can keep a needle-shy woman on treatment long enough to see results.
Mochi Health Cost: What You Actually Pay
Mochi charges in two parts. You pay a $79 monthly membership, plus a separate price for your medicine. Since August 2026, the medicine price rises as your dose goes up. Older reviews that quote one flat price are out of date.
- Compounded semaglutide shot: about $140 to $270 a month, membership included
- Compounded tirzepatide shot: about $170 to $280 a month, membership included
- Membership on its own: $79 a month · About $50 a month on the 12-month prepaid plan
- New members: first month of membership free, though not in every state
That free month makes the start cheap. At the starting dose, your first bill for semaglutide is about $60.
Brand-name drugs cost more. Wegovy pens run about $350 a month through Novo Nordisk's self-pay program. Zepbound starts at about $300 a month through LillyDirect. With Mochi, the membership comes on top of either.
Mochi advertises no hidden fees, and the standard plan has no required add-ons. Over a full year, plan on about $1,700 to $3,300 with the membership. Where you land depends on the drug and how high your dose climbs. Our Mochi Health cost breakdown walks through the math.
Reputation: What Patients and Regulators Say
Mochi holds a 4.5 out of 5 rating on Trustpilot. That score comes from about 19,500 reviews, as of late September 2026.
Happy reviewers praise caring, thorough doctors and an easy sign-up. Unhappy ones mention slow support and trouble with refill scheduling. Some are surprised that the $79 membership comes on top of the medicine.
The bigger story is Aequita, a Washington pharmacy that was one of Mochi's main suppliers. In March 2025, state regulators ordered it to stop sterile compounding. Inspectors found unlicensed workers handling medicine. Patients who relied on Aequita faced shipping delays.
Mochi has since spread its orders across more than 30 partner pharmacies, by its own count. New reporting in 2026 added detail on the Aequita failures, including state video of the 2025 raid. It is a fair reason to ask which pharmacy fills your prescription.
There is also a rule change in progress. On April 30, 2026, the FDA proposed dropping semaglutide, tirzepatide and liraglutide from the 503B bulks list. That list covers large outsourcing facilities, not the smaller 503A pharmacies that fill one patient's prescription at a time.
The comment period closed on July 30, 2026. No final rule has been reported since. How much it matters to you depends on which kind of pharmacy fills your order.
Who Mochi Health Is Best For
Mochi suits people who want obesity medicine know-how without paying for an in-person weight clinic. That matters in midlife. Women in their 40s and 50s often notice weight moving to the belly and appetite changing. Providers trained in obesity medicine treat that as biology, not a lack of willpower.
Mochi also runs a menopause hormone therapy line. It offers FDA-approved estradiol as a pill or patch, plus progesterone. Estradiol pills start at about $25 a month, on top of the membership. Our HRT cost guide shows how that compares.
- Adults with a BMI, a weight-to-height score, of 27 or more who have not been helped by lifestyle changes alone
- Women in perimenopause or menopause managing weight and blood sugar changes
- People who want compounded GLP-1s for less than brand-name cash prices, even as the price rises with dose
- Needle-shy patients who prefer a semaglutide pill
- People in rural areas with no obesity medicine clinic nearby
- Patients comfortable arranging their own lab tests
Mochi is a weaker fit if you want labs included or insurance billing for compounded medicine. It is also weaker if a steady pharmacy supply matters to you above all else.
Verdict
Mochi Health is one of the heavyweights of GLP-1 telehealth. Its obesity medicine doctors and wide menu, from shots to pills, are real advantages. Even with per-dose pricing, compounded medicine stays well below brand-name cash prices. For women in perimenopause and menopause, doctors who understand hormonal weight gain are worth the $79 membership.
The pharmacy record is the fair knock against Mochi. The Aequita shutdown was a serious safety event. The FDA's 503B proposal adds some longer-term supply risk too. Go in with open eyes. Ask which pharmacy will fill your prescription, and check that its state license is current.
Frequently asked questions
What does Mochi Health cost per month?+–
Mochi charges a $79 monthly membership plus your medicine, priced by dose. With the membership, compounded semaglutide shots run about $140 to $270 a month. Compounded tirzepatide runs about $170 to $280. New members get the first month of membership free, though not in every state.
Does Mochi Health's price go up as I need higher doses?+–
Yes, since Mochi's August 2026 pricing change. Semaglutide medicine runs about $60 to $190 a month, depending on your dose. Tirzepatide runs about $90 to $200. The $79 membership comes on top. This replaced Mochi's old flat pricing.
What happened with Mochi Health's pharmacy partner Aequita?+–
In March 2025, Washington regulators ordered Aequita to stop sterile compounding. Inspectors found unlicensed workers handling medicine. Mochi now spreads its orders across a network of partner pharmacies, which it runs as a marketplace. Ask which pharmacy will fill your prescription, and check that its state license is current.
Are Mochi's providers actual obesity medicine specialists?+–
Some are. Mochi says it has more than 400 board-certified providers. Several of its doctors are also board-certified in obesity medicine, a specialty built on the biology of weight. Mochi does not say every provider holds that certification, so you can ask for one when you choose.
Does Mochi Health include lab work?+–
No. Lab tests are not part of the membership. If your provider asks for bloodwork, you arrange it and pay for it separately, often through your own doctor.
What is the regulatory risk for Mochi's compounded medications?+–
On April 30, 2026, the FDA proposed not to add semaglutide, tirzepatide and liraglutide to the 503B bulks list. That list covers large outsourcing facilities, not the 503A pharmacies that fill one patient's prescription at a time. The comment period closed on July 30, 2026, and no final rule has been reported since. The impact depends on which kind of pharmacy fills your order.
Can Mochi Health prescribe to patients in all 50 states?+–
Yes. Mochi says you can join from anywhere in the United States, and it lists no state limits for compounded medicine.